Life Sciences
Safety Signals Are Speaking Every Language. Are You Listening?
At last month’s 5th Pharmacovigilance & Drug Safety Conference in…
What It Feels Like to Wait for a Treatment That Doesn’t Exist
One patient’s journey through rare disease diagnosis, clinical trial participation,…
Clinical Trials Are Complex. Workflows Shouldn’t Make Them Harder.Â
As clinical trials scale across systems, vendors, countries, and languages,…
Accessibility in Clinical Trials Isn’t Optional. It’s Foundational to Better Recruitment.Â
Patient recruitment has always been one of the most challenging…
Welo Life Sciences: Built for Life Sciences Translation, Regulatory Content, and Global ComplianceÂ
This is the environment where life sciences translation, regulatory content…
Creating a Future-Ready Model for a Global MedTech Leader
Discover how a global MedTech leader deployed OPAL Enable to…
EMA’s Guiding Principles on LLMs: Reshaping Regulatory Translation
Discover how the EMA’s Guiding Principles on LLMs are transforming…
Multilingual Training Made Simple for Life Sciences Leader
Delivering a 50-minute training video subtitled in 13 languages as…
How FDA and EMA Shape Linguistic Validation in Clinical Research
As clinical research becomes global, understanding how to meet regulatory…
Regulatory Compliance in Pharmacovigilance Translations: EMA, FDA, and MHRA Requirements Explained
As the range of medicinal products grows, regulatory bodies such…